ImmuPharma (GB:IMM) has released an update.
ImmuPharma PLC has appointed Ashley Clarke as the new Company Secretary, a move expected to bolster the company’s financial strategy and management. With her extensive experience in finance and deep knowledge of ImmuPharma’s operations, Clarke is positioned to drive its strategic financial growth. This appointment reflects ImmuPharma’s commitment to enhancing its financial leadership team.
For further insights into GB:IMM stock, check out TipRanks’ Stock Analysis page.